1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Beckman Coulter

Anonymous board for Beckman Coulter


Sort By:
Title
Replies Views
Last Message ↑
  1. Anonymous
    Replies:
    8
    Views:
    12,183
  2. Anonymous
    Replies:
    3
    Views:
    8,207

Thread Display Options

Loading...